Theracurmin®

A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.

Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H.

Cancer Chemother Pharmacol. 2013 Jun; 71 (6): 1521-1530.

Clinical Application of “Curcumin”, a Multi-Functional Substance.

Shimatsu A, Kakeya H, Imaizumi A, Morimoto T, Kanai M, Maeda S.

Anti-Aging Medicine . 2012 Mar; 9(2): 75-83.

Highly Bioavailable Curcumin Derivative Ameliorates Crohn’s Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Sugimoto K, Ikeya K, Bamba S, Andoh A, Yamasaki H, Mitsuyama K, Nasuno M, Tanaka H, Matsuura A, Kato M, Ishida N, Tamura S, Takano R, Tani S, Osawa S, Nishihira J, Hanai H.

J Crohns Colitis.2020 May 15. doi: 10.1093/ecco-jcc/jjaa097. Online ahead of print.

Therapeutic applications of curcumin for patients with pancreatic cancer.

Kanai M.

World J Gastroenterol. 2014 Jul; 20 (28): 9384-9391.

Effects of Curcumin Supplementation on Exercise-Induced Oxidative Stress in Humans.

Takahashi M, Suzuki K, Kim HK, Otsuka Y, Imaizumi A, Miyashita M, Sakamoto S.

Int J Sports Med. 2014 Jun; 35 (6): 469-475.

Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects.

Chung H, Yoon SH, Cho JY, Yeo HK, Shin D, Park JY.

International Journal of Clinical Pharmacology and Therapeutics. 2021 Oct; 59(10): 684-690.